Literature DB >> 15756653

Differences in tumor core distribution between palpable and nonpalpable prostate tumors in patients diagnosed using extensive transperineal ultrasound-guided template prostate biopsy.

Takayoshi Demura1, Takaya Hioka, Tsuyoshi Furuno, Tatsuo Kaneta, Hiroko Gotoda, Shunji Muraoka, Toshihiro Sato, Tsutomu Mochizuki, Satoshi Nagamori, Nobuo Shinohara.   

Abstract

BACKGROUND: The authors performed extensive transperineal ultrasound-guided template prostate biopsies to investigate carcinoma core distribution.
METHODS: Between August 2000 and May 2004, 371 men underwent template biopsies. Three hundred twelve patients had not undergone a previous biopsy (first group) and 59 had undergone previous transrectal sextant biopsies (repeat group). Of the 312 patients in the first group, 236 had normal digital rectal examination (DRE) findings (DRE- first group) and 76 patients had an abnormal DRE (DRE+ first group). A mean of 20.1 biopsy cores (range, 9-38 cores) was taken from the entire prostate. The region > 2.0 cm from the rectal face of the prostate was defined as the anterior region and the remaining area was defined as the posterior region.
RESULTS: In the DRE- first group, the carcinoma core rate (number of tumor cores/number of biopsy cores) in the anterior region (7.2%) did not differ from that of the posterior region (7.3%) (P = 0.9635). However, in the DRE+ first group, the carcinoma core rate in the posterior region (22.0%) was found to be higher than in the anterior region (13.2%) (P < 0.0001). In the repeat group, the carcinoma core rate in the posterior region (3.1%) was significantly (P = 0.0008) lower than that exhibited in the anterior region (7.2%).
CONCLUSIONS: The results of the current study suggest that nonpalpable prostate carcinoma is distributed equally within the entire prostate, although palpable carcinoma is distributed mainly in the posterior region and many of the tumor foci in the anterior region may be missed by a transrectal sextant biopsy. The examination of radical prostatectomy specimens is required to prove these results. (c) 2005 American Cancer Society.

Entities:  

Mesh:

Year:  2005        PMID: 15756653     DOI: 10.1002/cncr.21020

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

Review 1.  Robotic prostate biopsy and its relevance to focal therapy of prostate cancer.

Authors:  Henry Ho; John S P Yuen; Christopher W S Cheng
Journal:  Nat Rev Urol       Date:  2011-09-20       Impact factor: 14.432

2.  Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer.

Authors:  Satoru Kawakami; Nobuhiko Hyochi; Junji Yonese; Masataka Yano; Yasuhisa Fujii; Yukio Kageyama; Iwao Fukui; Kazunori Kihara
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

Review 3.  Transperineal biopsy of the prostate--is this the future?

Authors:  Dwayne T S Chang; Benjamin Challacombe; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2013-09-24       Impact factor: 14.432

4.  Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers.

Authors:  Dmitry Volkin; Baris Turkbey; Anthony N Hoang; Soroush Rais-Bahrami; Nitin Yerram; Annerleim Walton-Diaz; Jeffrey W Nix; Bradford J Wood; Peter L Choyke; Peter A Pinto
Journal:  BJU Int       Date:  2014-10-18       Impact factor: 5.588

Review 5.  Progression on active surveillance for prostate cancer in Black men: a systematic review and meta-analysis.

Authors:  Hari T Vigneswaran; Luke Mittelstaedt; Alessio Crippa; Martin Eklund; Adriana Vidal; Stephen J Freedland; Michael R Abern
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-07-08       Impact factor: 5.554

6.  Beyond diagnosis: evolving prostate biopsy in the era of focal therapy.

Authors:  J L Dominguez-Escrig; S R C McCracken; D Greene
Journal:  Prostate Cancer       Date:  2010-12-09

7.  Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy.

Authors:  Adam W Nelson; Rebecca C Harvey; Richard A Parker; Christof Kastner; Andrew Doble; Vincent J Gnanapragasam
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

8.  Transperineal ultrasound-guided 12-core prostate biopsy: an extended approach to diagnose transition zone prostate tumors.

Authors:  Ming-Hua Yao; Li-Ling Zou; Rong Wu; Le-Hang Guo; Guang Xu; Juan Xie; Pei Li; Shuai Wang
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

Review 9.  Focal therapy for prostate cancer: rationale and treatment opportunities.

Authors:  V Kasivisvanathan; M Emberton; H U Ahmed
Journal:  Clin Oncol (R Coll Radiol)       Date:  2013-06-04       Impact factor: 4.126

10.  Pre-plan parameters predict post-implant D90 ≥ 140 Gy for (125)I permanent prostate implants.

Authors:  Jes Alexander; Vivian Weinberg; Alexander R Gottschalk; I-Chow Joe Hsu; Katsuto Shinohara; Mack Roach
Journal:  J Contemp Brachytherapy       Date:  2014-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.